losartan has been researched along with 2,2'-(hydroxynitrosohydrazono)bis-ethanamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bache, RJ; Bitterman, P; Liu, J; Tian, B | 1 |
| Campbell, WB; Edwards, EM; Gauthier, KM; Holmes, B; Zhang, DX | 1 |
2 other study(ies) available for losartan and 2,2'-(hydroxynitrosohydrazono)bis-ethanamine
| Article | Year |
|---|---|
Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/PKB.
Topics: Angiotensin II; Animals; Apoptosis; Fibroblasts; Interleukin-1; Losartan; Male; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroso Compounds; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasoconstrictor Agents | 2003 |
Angiotensin II dilates bovine adrenal cortical arterioles: role of endothelial nitric oxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenal Cortex; Angiotensin II; Animals; Arterioles; Cattle; Endothelium, Vascular; Losartan; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2005 |